Back to results
US 2025/0017903 A1Published application
Use of edaravone in treatment of autism spectrum disorder
AssigneeShanghai Auzone Biological Technology Co., Ltd.
InventorsYi ZHOU, Xin YE
Life of this patent
Estimating the term…
Abstract
The present invention relates to a use of edaravone in the treatment of autism spectrum disorder.
Claims7
Use of edaravone or a pharmaceutically acceptable salt or an analog or a derivative thereof in the preparation of a medicament for treating autism spectrum disorder.
Dependencies are inferred from the claim text.